I Kline
Impact in
- Oncology top 10%
- Cancer Treatment and Pharmacology
- Metal complexes synthesis and properties
- Cancer Cells and Metastasis
- Hematology top 10%
Papers in
-
- Cancer therapeutics and mechanisms 5
- Retinoids in leukemia and cellular processes 3
-
- Acute Lymphoblastic Leukemia research 15
- Co-authors
- John M. Venditti (21 shared papers)A Goldin (17 shared papers)Nathan Mantel (6 shared papers)Joseph Leighton (8 shared papers)Abraham Goldin (10 shared papers)V.S. Waravdekar (5 shared papers)Alphonse E. Sirica (3 shared papers)Morris Belkin (3 shared papers)
- Journals
- JNCI Journal of the National Cancer Institute (4 papers)Science (2 papers)Chemotherapy (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)Cancer (1 paper)
- Partner nations
- United StatesMalaysiaIndia
In The Last Decade
I Kline
58 papers receiving 566 citations
Peers
Comparison fields: 5 of 88
- Oncology 266
- Hematology 85
- Biotechnology 49
- Cancer Research 75
- Molecular Biology 242
Countries citing papers authored by I Kline
This map shows the geographic impact of I Kline's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Kline with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Kline more than expected).
Fields of papers citing papers by I Kline
This network shows the impact of papers produced by I Kline. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Kline. The network helps show where I Kline may publish in the future.
Co-authors
The 25 scholars most cited alongside I Kline, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1966 | 88 | |
| 2 | 1973 | 56 | |
| 3 | 1972 | 41 | |
| 4 | Chemotherapy of leukemia L1210 in mice with 1-beta-d-arabinofuranosylcytosine hydrochloride. I. Influence of treatment schedules. | 1966 | 34 |
| 5 | Pathogenesis of tumor invasion. I. Interaction between normal tissues and transformed cells in tissue culture. | 1959 | 31 |
| 6 | 1968 | 26 | |
| 7 | Some observations on the response of four established human cell strains to hydrocortisone in tissue culture. | 1957 | 26 |
| 8 | Enhancement of the effectiveness of daunorubicin (NSC-82151) or adriamycin (NSC-123127) against early mouse L1210 leukemia with ICRF-159 (NSC-129943). | 1975 | 25 |
| 9 | The antileukemic effectiveness of 5-fluorouracil and methotrexate in the combination chemotherapy of advanced leukemia L1210 in mice. | 1966 | 25 |
| 10 | 1953 | 20 | |
| 11 | Adequacies and inadequacies in assessing murine toxicity data with antineoplastic agents. | 1979 | 19 |
| 12 | Evaluation of combination chemotherapy with three drugs. | 1968 | 19 |
| 13 | Effect of combination treatment with 5-azacytidine and cytidine on the life-span and spleen and bone marrow cells of leukemic (L1210) and nonleukemic mice. | 1970 | 17 |
| 14 | The similarity in histologic appearance of some human cancer and normal cell strains in sponge-matrix tissue culture. | 1957 | 17 |
| 15 | Chemotherapy of leukemia L1210 in mice with 1-beta-D-arabinofuranosylcytosine hydrochloride. II. Effectiveness against intracerebrally and subcutaneously inoculated leukemic cells. | 1966 | 17 |
| 16 | Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors. | 1976 | 16 |
| 17 | Comparison of 5-fluorouracil and ftorafur. I. Quantitative and qualitative differences in toxicity to mice. | 1976 | 16 |
| 18 | Protection with N-acetyl-L-cysteine (NSC-111180) against isophosphamide (NSC-109724) toxicity and enhancement of therapeutic effect in early murine L1210 leukemia. | 1974 | 16 |
| 19 | 1956 | 13 | |
| 20 | Studies on human cancer using sponge matrix tissue culture. II. Invasion of connective tissue by carcinoma (strain HeLa). | 1954 | 12 |
About I Kline
I Kline is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health, Genetics, Oncology and Immunology, having authored 60 papers that have together received 702 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (15 papers), Chronic Lymphocytic Leukemia Research (12 papers), Cancer Treatment and Pharmacology (5 papers), Cancer therapeutics and mechanisms (5 papers), Chronic Myeloid Leukemia Treatments (5 papers), T-cell and Retrovirus Studies (5 papers), Cancer Research and Treatments (3 papers) and Retinoids in leukemia and cellular processes (3 papers). The work is most often cited by research in Oncology (266 citations), Hematology (85 citations), Biotechnology (49 citations), Cancer Research (75 citations) and Molecular Biology (242 citations). I Kline has collaborated with scholars based in United States, Malaysia and India. Frequent co-authors include John M. Venditti, A Goldin, Nathan Mantel, Joseph Leighton, Abraham Goldin, V.S. Waravdekar, Alphonse E. Sirica, Morris Belkin, Richard Woodman and Michael Belkin. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Science, Chemotherapy, Journal of Pharmacology and Experimental Therapeutics and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.